Announcements Trials
Browse Landscape

Phase

Phase NA 10Phase 1 4Phase 4 3Phase 2 3Phase 3 1Phase 1/2 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1Endocrine 1Breast 1

Conditions

Pancreatic Cyst 1Multiple Endocrine Neoplasia Type 1 1Depression 1Breast Neoplasms 1Alcoholism 1

Interventions

Cyclophosphamide 739Cisplatin 687Gemcitabine 641Bevacizumab 615Carboplatin 604Paclitaxel 600Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 360Capecitabine 342Filgrastim 333Etoposide 328Dexamethasone 312Irinotecan 309pembrolizumab 279Leucovorin 274Cetuximab 267Cytarabine 242Erlotinib Hydrochloride 231Prednisone 227Nivolumab 227Trastuzumab 225Bortezomib 221Vincristine 220Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Completed × Ethanol × Clear all
NCT01698918 2023-05-03

BOLERO-4

Novartis

Phase 2 Completed
202 enrolled 19 charts
Breast

Breast Neoplasms

NCT01475331 2018-03-20

The CHARM Trial: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts

Milton S. Hershey Medical Center

Phase 2 Completed
46 enrolled 8 charts
Gastrointestinal

Pancreatic Cyst

NCT00851669 2013-07-16

MEADOW/Bridge

University of Rochester

Phase 2 Completed
91 enrolled
Endocrine

Alcoholism, Depression, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡